Stephens Consulting, LLC Novartis Ag Transaction History
Stephens Consulting, LLC
- $392 Billion
- Q3 2024
A detailed history of Stephens Consulting, LLC transactions in Novartis Ag stock. As of the latest transaction made, Stephens Consulting, LLC holds 109 shares of NVS stock, worth $10,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 132
17.42%
Holding current value
$10,724
Previous $14.1 Million
10.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$796 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$687 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$568 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...